Uncategorized

Of 544 records screened in the 2025 systematic review, one clinical study survived inclusion — a retrospective series of twelve patients. BPC-157 is among the most discussed compounds in the research peptide market and among the least tested in humans. Both of those things are true at once, and most writing about it manages to…